Control Bionics Seeks Shareholder Nod for Shares

Control Bionics Ltd. (AU:CBL) has released an update.

Control Bionics Ltd., a medical device company known for its innovative technology aiding communication for patients with severe illnesses, has updated its approach to the issuance of placement shares and options, now seeking shareholder approval. The company, which has recently expanded its product range with the TGA-approved DROVE wheelchair module and the NeuroStrip® for various applications, continues to grow its presence in markets across North America, Australia, Singapore, and Japan.

For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.